Kepler Cheuvreux Suisse SA Buys Shares of 6,350 McKesson Corporation $MCK

Kepler Cheuvreux Suisse SA bought a new stake in McKesson Corporation (NYSE:MCK) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 6,350 shares of the company’s stock, valued at approximately $4,906,000.

Several other large investors have also modified their holdings of MCK. Norges Bank purchased a new position in McKesson in the 2nd quarter valued at $1,346,661,000. Alliancebernstein L.P. increased its stake in McKesson by 150.4% in the 2nd quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock valued at $1,661,956,000 after buying an additional 1,362,386 shares during the period. Arrowstreet Capital Limited Partnership raised its position in McKesson by 56.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock worth $906,109,000 after buying an additional 446,060 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its position in McKesson by 45.6% during the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock worth $610,977,000 after buying an additional 261,296 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of McKesson by 2.0% in the 2nd quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company’s stock worth $8,846,186,000 after acquiring an additional 232,286 shares during the period. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

MCK has been the topic of several analyst reports. Mizuho lifted their target price on shares of McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Evercore reissued an “outperform” rating on shares of McKesson in a report on Thursday, March 5th. Morgan Stanley restated an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research report on Thursday, January 29th. Robert W. Baird set a $968.00 price objective on McKesson in a report on Wednesday, January 14th. Finally, Raymond James Financial set a $970.00 target price on McKesson in a research report on Thursday, March 5th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $960.93.

McKesson Stock Down 1.4%

Shares of MCK opened at $928.60 on Wednesday. McKesson Corporation has a 52-week low of $635.00 and a 52-week high of $999.00. The company has a 50-day simple moving average of $886.79 and a 200-day simple moving average of $820.88. The company has a market capitalization of $113.74 billion, a PE ratio of 26.71, a P/E/G ratio of 1.52 and a beta of 0.38.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter in the previous year, the firm earned $8.03 earnings per share. The firm’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s payout ratio is 9.43%.

Insider Buying and Selling at McKesson

In related news, Director Maria Martinez sold 349 shares of McKesson stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares of the company’s stock, valued at approximately $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 3,868 shares of company stock worth $3,743,820. Corporate insiders own 0.08% of the company’s stock.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.